Long-term outcomes of systemic corticosteroid-sparing immunomodulatory therapy for Birdshot Retinochoroidopathy.
Massachusetts Eye Research and Surgery Institution (MERSI) , Waltham , Massachusetts , USA.
Ocular Immunology and Uveitis Foundation , Weston , Massachusetts , USA.
Department of Ophthalmology, Tianjin Medical University General Hospital , Tianjin , China.
Retina and Vitreous Department, Clinica Privada de Ojos, Mar del Plata , Buenos Aires , Argentina.
School of Medicine, University of Glasgow , Glasgow , United Kingdom.
Department of Ophthalmology, Harvard Medical School , Boston , Massachusetts , USA.
- Published Article
Ocular Immunology and Inflammation
Informa UK (Taylor & Francis)
- Publication Date
Sep 30, 2019
Purpose: To report the visual prognosis, electroretinography (ERG) and perimetry outcomes of systemic corticosteroid-sparing immunomodulatory treatment (IMT) for birdshot retinochoroidopathy (BSRC). Methods: Retrospective non-comparative case series of 132 patients (264 eyes) with BSRC treated with IMT from Massachusetts Eye Research and Surgery Institution. Results: The average follow-up time was 60.1 months. After one year on IMT, 39.4% showed no clinically active inflammation. After 5 years of IMT, 78.0% had no signs of clinical inflammation. No significant differences were observed on best-corrected visual acuity (BCVA), ERG parameters, and perimetry parameters between baseline and subsequent visits on IMT. Conclusion: Long-term systemic corticosteroid-sparing IMT was associated with a low rate of BSRC disease exacerbation. While differences were seen on testing parameters, they were not consistent trends and difference were attributed to variability of testing or fluctuation of inflammation that may be expected in the course of the disease.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 12/31/2019 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/31567006